---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-006760"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2022-03-18T23:59:59+00:00"
generated_at: "2026-06-26T21:50:54.581904+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BioLife Solutions receives Nasdaq delisting notice for delayed 10-K filing

## Summary
- Received Nasdaq notice on March 17, 2022 for failure to timely file 2021 10-K.
- Has until May 16, 2022 to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant extension until September 12, 2022.
- CFO states Form 10-K expected to be filed no later than March 31, 2022.

## SEC filing metadata
- accession: 0001437749-22-006760
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2022-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000143774922006760/0001437749-22-006760-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000143774922006760/bioli20220318_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-006760
- JSON: https://secwatch.observer/filing/0001437749-22-006760.json
- Plain text: https://secwatch.observer/filing/0001437749-22-006760.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.